Corcept Therapeutics | CORT - PE Price to Earnings


Corcept Therapeutics reported 41.9 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
ANI Pharmaceuticals 37.99 60.68 Dec/2025
Aurora Cannabis 23.27 0 Sep/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Corcept Therapeutics 41.9 52.28 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
J&J 23.62 0.86 Dec/2025
Knight Therapeutics 91.09 0.73 Sep/2025
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Merck 13.92 5.08 Dec/2025
Novartis 15.74 0.15 Sep/2025
Novartis 16.05 2.92 Sep/2025
Pacira 52.68 23.44 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025